Skip to content
Precision for Medicine
Category Hero Image category_03_01

Target Validation, Biomarker Validation, and Safety

Effective validation of therapeutic targets and biomarkers

Precision for Medicine, with a specific focus on histopathology and access to diverse biospecimens, provides a range of human tissue–based research services from the preclinical to clinical stages of development. We specialize in various programs involving small molecule, large molecule, and advanced therapeutics (gene and cell therapies). Our expertise in genomics and cell biology supports you in understanding target expression and localization, determining tumor biology and cellular interplay, and characterizing novel therapeutic entities.

Precision’s technologies providing biomarker and safety insight

  • Explore Explore

    Target Expression

    Using a proprietary qRT-PCR-based platform, whole body target expression data supports target validation, drug repurposing, evaluation of potential clinical safety concerns, and validation of animal models.
    Explore
  • Explore Explore

    Cell-Based Assays

    Developing and qualifying 2D and 3D human in vitro cell-based models, using a broad range of human primary cell types. These models are further utilized in bioassays, with the analysis enabling a variety of endpoints.
    Explore
  • Explore Explore

    Fluorescence In Situ Hybridization (FISH)/ISH

    Development of multiplex FISH/ISH assays to detect abnormalities in a range of tissues, including hematological and solid organ tumors.
    Explore
  • Explore Explore

    Multiplex immunofluorescence (mIF)

    Automated multiplex immunofluorescence services that enable quantitative visualization of up to 9 markers in tissue and liquid biopsies.
    Explore
  • Explore Explore
    tissue-slide

    lmmunohistochemistry (IHC)

    End-to-end IHC solutions including kitting, sample logistics, staining via all major platforms, and in-house pathology services.
    Explore
  • Explore Explore
    tissue

    Tissue Biospecimens

    Thousands of IRB-approved, clinically annotated biospecimens, including samples characterized via next-generation sequencing (NGS), are available to help researchers optimize biomarker and diagnostic development. These are ready to ship the same day to your lab.
    Explore

Histopathology labs supporting beyond target and biomarker validation

Precision’s histopathology labs offer comprehensive services for target and biomarker validation. Our team of board-certified pathologists specialize in various areas of clinical research, including companion diagnostics development, and in vitro diagnostics (IVD) development.

  • iStock-1370585977

    Winston-Salem, North Carolina, US

    IHC/mIF Stainers & Scanners

    • Dako Autostainer Link 48
    • Dako PT Link
    • Leica Bond II
    • Ventana BenchMark ULTRA
    • Aperio GT 450
    • 3DHISTECH


    Certifications

    • CAP/CLIA
    • ISO 9001:2005
  • iStock-1130924353

    Houston, Texas, US

    IHC/mIF Stainers & Scanners

    • Leica Bond RX
    • Akoya Vectra Polaris
    • Aperio GT 450
    • InForm / HALO AP
    • Halo/AI


    Certifications

    • CLIA
    • GxP
  • iStock-980627542

    Royston, UK

    IHC/mIF Stainers & Scanners

    • Leica Bond RX
    • Dako Autostainer + PT Link
    • Ventana Discovery ULTRA 
    • Aperio AT2
    • Akoya Vectra Polaris
    • InForm / HALO AP


    Certifications

    • GLP
    • GCLP

Journey of a
Therapeutic Antibody:
From Preclinical to
Clinical Proof of Concept

Gain comprehensive insights into the process of developing therapeutic antibodies from discovery to clinical success.

eBook

Journey of a Therapeutic Antibody: Preclinical to Clinical Proof of Concept

Download eBook
Journey of a Therapeutic Antibody: Preclinical to Clinical Proof of Concept

Approaches for target and biomarker validation, and for therapeutic characterization

Precision’s target and biomarker validation and safety services include consultative study design and assay development, analysis and interpretation of data, and data reporting.

target validation vert-1

Explore Precision’s other specialty assay areas

  • Explore Explore
    Immune-monitoring

    Immune Monitoring

    Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID® immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

    Explore
  • Explore Explore
    Bioanalytical

    Bioanalytical Testing

    At Precision, we understand the complexities of immunogenicity testing and other bioanalytical methods, with a leadership team that continues to shape and inform regulatory guidance. 

    Explore
  • Explore Explore

    Tissue Biopsy Analysis

    At Precision for Medicine, we’re committed to delivering gold-standard tissue sourcing, processing, and analysis services.

    Explore

Discover the Precision blog

Read our blog to gain more insights and discover work that Precision has supported.

Read: Investor Relations, Clinical Operations, and the Future of Biotech Financing Investor Relations, Clinical Operations, and the Future of Biotech Financing

Clinical Trials - Translational Research - Early Phase Research

Investor Relations, Clinical Operations, and the Future of Biotech Financing

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548862, hs_child_table_id=0, hs_updated_at=1716454315513, hs_published_at=1761062733198, description=Teresa is a respected business development strategist, building successful clinical programs for clients in Massachusetts. She is an innovator of fresh approaches to biomarker planning, translational solutions, and clinical study design. Her experience spans the execution of Phase 1-4 clinical trials, specialty lab services, companion and in vitro diagnostic strategies, and biomarker data management., avatar=Image{width=700,height=700,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Teresa-Pokladowski-300x300.png',altText='Teresa-Pokladowski-300x300',fileId=168135942975}, linkedin=https://www.linkedin.com/in/teresapokladowski/, lastname=Pokladowski, hs_initial_published_at=1713363230550, hs_created_by_user_id=5166971, hs_created_at=1713362443509, hs_is_edited=false, hs_deleted_at=0, name=Teresa, job=Regional Vice President, Clinical Business Solutions, North America, slug=teresa-pokladowski, hs_updated_by_user_id=26433386}, second={hs_id=197608580658, hs_child_table_id=0, hs_updated_at=1760465121471, hs_published_at=1761062733198, description=Hannah Dereseiwicz is a strategic force in investor relations, helping biotech innovators translate complex science into compelling narratives that drive engagement and growth. With a track record spanning commercial launches, M&A activity, and high-stakes communications, she brings clarity, confidence, and momentum to every stage of a company’s journey. Hannah’s approach is defined by the three A’s—ambitious, approachable, and authentic—making her a trusted partner for teams looking to elevate their story and connect with the audiences that matter most., avatar=Image{width=636,height=476,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Hannah%20Deresiewicz.webp',altText='Hannah Deresiewicz',fileId=197608718507}, lastname=Deresiewicz, hs_initial_published_at=1760465283803, hs_created_by_user_id=26433386, hs_created_at=1760464991513, hs_is_edited=false, hs_deleted_at=0, name=Hannah, job=Executive Vice President, Managing Director Precision AQ – Investor Relations & External Communications, slug=hannah-deresiewicz, hs_updated_by_user_id=26433386}, third={}})
  • Teresa P. avatar

    Teresa P.

  • Hannah D. avatar

    Hannah D.

Discover
Read: The Immune System's Secret Language: Unlocking Cellular Communication The Immune System's Secret Language: Unlocking Cellular Communication

Translational Research - Lab Services

The Immune System's Secret Language: Unlocking Cellular Communication

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1754641583843, hs_published_at=1761062733198, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/rob.png',altText='rob',fileId=194099000843}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1758208027822, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover
Read: How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development

Translational Research - Biomarkers - Oncology

How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1754641583843, hs_published_at=1761062733198, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/rob.png',altText='rob',fileId=194099000843}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1758208027822, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover

View some of Precision’s available biospecimens products